M-toin 50 mg Tablet

For Status Epilepticus and Non-emergent Loading Dose: Adult loading dose is 10 to 15 mg/kg at a rate not exceeding 50 mg/min. Pediatric loading dose is 15 to 20 mg/kg at a rate not exceeding 1 to 3 mg/kg/min or 50 mg/min, whichever is slower. Continuous monitoring of the electrocardiogram, blood pressure, and respiratory function is essential.

Directions from the U.S. FDA-approved label for Phenytoin — your doctor or pharmacist may advise differently.

Phenytoin Sodium Injection is contraindicated in patients with: A history of hypersensitivity to phenytoin, its inactive ingredients, or other hydantoins. Sinus bradycardia, sino-atrial block, second and third degree A-V block, and Adams-Stokes syndrome because of the effect of parenteral phenytoin on ventricular automaticity. A history of prior acute hepatotoxicity attributable to phenytoin.

Excerpt from the U.S. FDA-approved label for Phenytoin. Talk to a pharmacist or doctor before use.

Withdrawal Precipitated Seizure: May precipitate status epilepticus. Dose reductions or discontinuation should be done gradually. Serious Dermatologic Reactions: Discontinue phenytoin at the first sign of a rash, unless the rash is clearly not drug-related. If signs or symptoms suggest SJS/TEN, use of this drug should not be resumed and alternative therapy should be considered. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan hypersensitivity: If signs or symptoms of hypersensitivity are present, evaluate the patient immediately. Discontinue if an alternative etiology cannot be established.

Warnings and precautions excerpt from the U.S. FDA-approved label for Phenytoin — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are described elsewhere in the labeling: Cardiovascular Risk Associated with Rapid Infusion Withdrawal Precipitated Seizure, Status Epilepticus Serious Dermatologic Reactions Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan Hypersensitivity Hypersensitivity Hepatic Injury Hematopoietic Complications Local toxicity (Including Purple Glove Syndrome) Exacerbation of…

Excerpt from the U.S. FDA-approved label for Phenytoin — not a complete list. Talk to a pharmacist or doctor about side effects.

14 brands · 8 makers in the NepalDoc catalog — see the full Phenytoin guide →

Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).

Storage information from the U.S. FDA-approved label for Phenytoin.